---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-015818"
form_type: "8-K"
ticker: "BPTH"
cik: "0001133818"
company_name: "BIO-PATH HOLDINGS, INC."
filed_at: "2023-09-15T23:59:59+00:00"
generated_at: "2026-06-10T15:59:24.763726+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Bio-Path receives Nasdaq deficiency notice for bid price below $1.00

## Summary
- Nasdaq notified Bio-Path that closing bid price was below $1.00 for 30 consecutive business days.
- Company has 180 days, until March 11, 2024, to regain compliance by having bid price ≥ $1.00 for ten consecutive days.
- If not compliant by March 11, 2024, may seek a second 180-day cure period if eligible.
- Company may consider a reverse stock split to remedy the bid price deficiency.
- Listing on Nasdaq Capital Market under symbol BPTH is unaffected during cure period.

## SEC filing metadata
- accession: 0001558370-23-015818
- form_type: 8-K
- ticker: BPTH
- cik: 0001133818
- company_name: BIO-PATH HOLDINGS, INC.
- filed_at: 2023-09-15T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1133818/000155837023015818/0001558370-23-015818-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1133818/000155837023015818/bpth-20230913x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-015818
- JSON: https://secwatch.observer/filing/0001558370-23-015818.json
- Plain text: https://secwatch.observer/filing/0001558370-23-015818.txt

## Key facts
- Listing & Compliance Notices
  BIO-PATH HOLDINGS, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A)
  source text: September 13, 2023, Bio-Path Holdings, Inc. (the “Company”) received a letter (the “Letter”) from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock for the last 30 consecutive business days, the Company did not meet the minimum bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Rule”). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided an initial period of 180 calendar da
  evidence_url: https://www.sec.gov/Archives/edgar/data/1133818/000155837023015818/0001558370-23-015818-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.